HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clotilde Visée Selected Research

cilgavimab and tixagevimab drug combination

2/2024Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Clotilde Visée Research Topics

Disease

1COVID-19
02/2024

Drug/Important Bio-Agent (IBA)

1cilgavimabIBA
02/2024
1tixagevimabIBA
02/2024
1cilgavimab and tixagevimab drug combinationIBA
02/2024